Snapshot from Apr 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Aristides Maniatis
Person

Aristides Maniatis

Tracked across 1 events · 7 articles · First seen Feb 27, 2026 · Last active Mar 02, 2026

Sentiment
20
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 20
Regulatory
FDA Approves Novo Nordisk's Somapacitan for Pediatric Growth Disorders
Aristides Maniatis, as an investigator in the REAL8 trial and founder of Rocky Mountain Pediatric Endocrinology, provided expert commentary on the benefits of Novo Nordisk===Somapacitan's once-weekly administration for children with growth disorders.
Feb 27, 2026 · 7 articles
Relationships (2)
Novo Nordisk===Somapacitan investigator ↔ Aristides Maniatis Aristides Maniatis was an investigator in the REAL8 study for Novo Nordisk===Som
Rocky Mountain Pediatric Endocrinology founder ↔ Aristides Maniatis Aristides Maniatis is the founder of Rocky Mountain Pediatric Endocrinology.
NEWSDESK
Track Aristides Maniatis live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.